No valuation for C2N Diagnostics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($95.0M) and the funding record below are the closest available signals.
- ·Watch C2N Diagnostics: the Monday email on marks, rounds and moves
C2N Diagnostics funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Early Stage VC | $10.0M | ▮ | ▮ |
| Mar 2024 | Early Stage VC | $25.0M | ▮ | ▮ |
Membership and data by Private Market View
How much has C2N Diagnostics raised?
C2N Diagnostics has raised $95 million in total; 2 of its rounds are on record. The largest on record was a $10 million early-stage round in May 2025.
C2N Diagnostics has filed 3 Form Ds with the SEC since 2024, most recently in May 2025 ($10 million sold to 1 investor).
How C2N Diagnostics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For C2N Diagnostics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about C2N Diagnostics
- How much has C2N Diagnostics raised?
- C2N Diagnostics has raised $95.0M in total funding across 2 recorded rounds.
- When did C2N Diagnostics last raise?
- C2N Diagnostics last raised in May 2025 (Early Stage VC), raising $10.0M.